The incidence of papillary thyroid carcinoma (PTC) increases significantly after exposure of the head and neck region to ionizing radiation, yet we know neither the steps involved in malignant transformation of thyroid epithelium nor the specific carcinogenic mode of action of radiation. Such increased tumor frequency became most evident in children after the 1986 nuclear accident in Chernobyl, Ukraine. In the eight years following the accident, the average incidence of childhood PTCs (chPTC) increased 70-fold in Belarus, 200-fold in Gomel, 10-fold in the Ukraine and 50-fold in Tschnigov, Kiev, Rovno, Shitomyr and Tscherkassy compared to the rate of about 1 tumor incidence per 106 children per year prior to 1986 (Likhtarev et al., 1995; Sobolev et al., 1997; Jacob et al., 1998). To study the etiology of radiation-induced thyroid cancer, we formed an international consortium to investigate chromosomal changes and altered gene expression in cases of post-Chernobyl chPTC. Our approach is based on karyotyping of primary cultures established from chPTC specimens, establishment of cell lines and studies of genotype-phenotype relationships through high resolution chromosome analysis, DNA/cDNA micro-array studies, and mouse xenografts that test for tumorigenicity. Here, we report the application of fluorescence in situ hybridization (FISH)-based techniques for the molecular cytogenetic characterization of a highly tumorigenic chPTC cell line, S48TK, and its subclones. Using chromosome 9 rearrangements as an example, we describe a new approach termed ‘BAC-FISH’ to rapidly delineate chromosomal breakpoints, an important step towards a better understanding of the formation of translocations and their functional consequences.

1.
Babcock M, Pavlicek A, Spiteri E, Kashork CD, Ioshikhes I, Shaffer LG, Jurka J, Morrow BE: Shuffling of genes within low-copy repeats on 22q11 (LCR22) by Alu-mediated recombination during evolution. Genet Res 13:2519–2532 (2003).
2.
Baverstock K, Egloff B, Pinchera A, Ruchti C, Williams D: Thyroid cancer after Chernobyl. Nature 359:21–22 (1992).
3.
Birnboim HC, Doly J: A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res 7:1513–1523 (1979).
4.
Bongarzone I, Pierotti MA, Monzini N, Mondellini P, Manenti G, Donghi R, Pilotti S, Grieco M, Santoro M, Fusco A, Vecchio G, Della Porta G: High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma. Oncogene 4:1457–1462 (1989).
5.
Bongarzone I, Monzini N, Borrello MG, Carcano C, Ferraresi G, Arighi E, Mondellini P, Della Porta G, Pierotti MA: Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of <X_Underline>ret</X_Underline> tyrosine kinase and the regulatory subunit R1α of cyclic AMP-dependant protein kinase A. Mol Cell Biol 13:358–366 (1993).
6.
Chang JKC: Papillary carcinoma of thyroid: classical and variants. Histol Histopathol 5:241–257 (1990).
7.
Chen H, Udelsman R: Papillary thyroid carcinoma: justification for total thyroidectomy and management of lymph node metastases. Surg Oncol Clin N Am 7:645–663 (1998).
8.
Fiegler H, Carr P, Douglas EJ, Burford DC, Hunt S, Scott CE, Smith J, Vetrie D, et al: DNA microarrays for comparative genomic hybridization based on DOP-PCR amplification of BAC and PAC clones. Genes Chromosomes Cancer 36:361–374 (2003).
9.
Fugazzola L, Pilotti S, Pinchera A, Vorontsova TV, Mondellini P, Bargarzone I, Greco A, Astakhova L, Butti MG, Demidchik EP: Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident. Cancer Res 55:5617–5620 (1995).
10.
Fung J, Hyun W, Dandekar P, Pedersen RA, Weier HUG: Spectral imaging in preconception/preimplantation genetic diagnosis (PGD) of aneuploidy: multi-colour, multi-chromosome screening of single cells. J Assist Reprod Genet 15:322–329 (1998).
11.
Fung J, Weier H-UG, Goldberg JD, Pedersen RA: Multilocus genetic analysis of single interphase cells by Spectral Imaging. Hum Genet 107:615–622 (2000).
12.
Fung J, Munné S, Weier H-UG: Detection of chromosome translocation products in single interphase cell nuclei, in Darzynkiewicz Z, Chrissman HA, Robinson JP (eds): Methods in Cell Biology, Vol. 64, Part B, Cytometry, Third Edition pp 97–114 (Academic Press, San Diego 2001a).
13.
Fung J, Weier H-UG, Pedersen RA, Zitzelsberger HF: Spectral imaging analysis of metaphase and interphase cells, in Rautenstrauss B, Liehr T (eds): FISH Technology-Springer Lab Manual, Chapter 29, pp 363–387 (Springer, Berlin 2001b).
14.
Garini Y, Macville M, du Manoir S, Buckwald RA, Lavi M, Katzir N, Wine D, Bar-Am I, et al: Spectral karyotyping. Bioimaging 4:65–72 (1996).
15.
Gembicki M, Stozharov AN, Arinchin AN, Moschik KV, Petrenko S, Khmara IM, Baverstock KF: Iodine deficiency in Belarusian children as a possible factor stimulating the irradiation of the thyroid gland during the Chernobyl catastrophe. Environ Health Perspec 105:1487–1490 (1997).
16.
Harper ME, Saunders GF: Localization of single copy DNA sequences on G-banded human chromosomes by in situ hybridization. Chromosoma 83:431–439 (1981).
17.
Herrmann ME, Mohamed A, Talpos G, Wolman SR: Cytogenetic study of a papillary thyroid carcinoma with a rearranged chromosome 10. Cancer Genet Cytogenet 57:209–217 (1991a).
18.
Herrmann MA, Hay ID, Bartelt DH, Ritland SR, Dahl RJ, Grant CS, Jenkins RB: Cytogenetic and molecular genetic studies of follicular and papillary thyroid cancers. J Clinical Invest 88:1596–1604 (1991b).
19.
Ioannou PA, Amemiya CT, Garnes J, Kroisel PM, Shizuya H, Chen C, Batzer M, de Jong PJ: A new bacteriophage P1-derived vector for the propagation of large human DNA fragments. Nat Genet 6:84–89 (1994).
20.
ISCN 2005: An International System for Human Cytogenetic Nomenclature. Shaffer L, Tommerup N (eds) (S. Karger, Basel 2005).</NBR_RefNumber><citation id="ref021"><no>21</no>Isola JJ, Kallioniemi OP, Chu LW, Fuqua SA, Hilsenbeck SG, Osborne CK, Waldman FM: Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. Am J Pathol 147:905–911 (1995).
22.
Jacob P, Goulko G, Heidenreich WF, Likhtarev I, Kairo I, Tronko ND, Bogdanova TI, Kenigsberg J, et al: Thyroid cancer risk to children calculated. Nature 392:31–32 (1998).
23.
Jacob P, Bogdanova TI, Buglova E, Chepurniy M, Demidchik Y, Gavrilin Y, Kenigsberg J, Meckbach R, Schotola C, Shinkarev S, Tronko MD, Ulanovsky A, Vavilov S, Walsh L: Thyroid cancer risk in areas of Ukraine and Belarus affected by the Chernobyl accident. Radiat Res 165:1–8 (2006).
24.
Jossart GH, Clark OH: Well-differentiated thyroid cancer. Curr Probl Surg 12:933–1024 (1994).
25.
Jossart GH, Greulich KM, Siperstein AE, Duh Q, Clark OH, Weier H-UG: Molecular and cytogenetic characterization of a t(1;10;21) translocation in the human papillary thyroid cancer cell line TPC-1 expressing the ret/H4 chimeric transcript. Surgery 118:1018–1023 (1995).
26.
Kallioniemi A, Kallioniemi O, Sudar D, Rutovitz D, Gray J, Waldman F, Pinkel D: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818–821 (1992).
27.
Kallioniemi OP, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW, Pinkel D: Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 10:231–243 (1994).
28.
Kazakov VS, Demidchik EP, Astakhova LN: Thyroid cancer after Chernobyl. Nature 359:21 (1992).
29.
Lehmann L, Greulich KM, Zitzelsberger H, Negele T, Spelsberg F, Bauchinger M, Weier HU: Cytogenetic and molecular genetic characterization of a chromosome 2 rearrangement in a case of human papillary thyroid carcinoma with radiation history. Cancer Genet Cytogenet 96:30–36 (1997).
30.
Likhtarev IA, Sobolev BG, Kairo IA, Tronko ND, Bogdanova TI, Oleinic VA, Epshtein EV, Beral V: Thyroid cancer in the Ukraine. Nature 375:365 (1995).
31.
Maniatis T, Fritsch EF, Sambrook J: Molecular Cloning: A Laboratory Handbook. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor 1986).
32.
Márquez C, Cohen J, Munné S: Chromosome identification in human oocytes and polar bodies by spectral karyotyping. Cytogenet Cell Genet 81:254–258 (1998).
33.
Mashkova TD, Oparina NY, Lacroix MH, Fedorova LI, Tumeneva IG, Zinovieva OL, Kisselev LL: Structural rearrangements and insertions of dispersed elements in pericentromeric α satellites occur preferably at kinkable DNA sites. J Mol Biol 305:33–48 (2001).
34.
Nagataki S, Ingbar SH: Autoregulation: effects of iodine, in Braverman LE, Utiger RD (eds): Werner and Ingbar’s the Thyroid, pp 306–312 (Lippincott, Philadelphia 1991).
35.
Nikiforov YE, Heffess CS, Korzenko AV, Fagin JA, Gnepp DR: Characteristics of follicular tumors and nonneoplastic thyroid lesions in children and adolescents exposed to radiation as a result of the Chernobyl disaster. Cancer 76:900–909 (1995).
36.
Ning Y, Laundon CH, Schrock E, Buchanan P, Ried T: Prenatal diagnosis of a mosaic extra structurally abnormal chromosome by spectral karyotyping. Prenat Diagn 19:480–482 (1999).
37.
Pierotti MA, Santoro M, Jenkins RB, Sozzi G, Bongarzone I, Grieco M, Monzini N, Miozzo M, et al: Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/TPC. Proc Natl Acad Sci USA 89:1616–1620 (1992).
38.
Riches AC, Herceg Z, Bryant P, Wynford-Thomas D: Radiation-induced transformation of SV 40-immortalized human thyroid epithelial cells by single and fractionated exposure to γ-radiation in vitro. Intern J Radiat Biol 66:757–765 (1994).
39.
Riches A, Herceg Z, Wang H, Bryant P, Armitage M, Gamble S, Arrand J, O’Reilly S, Seymour C, Mothersill C: Radiation-induced carcinogenesis. Genes Chromosomes Cancer 13:157–162 (1997).
40.
Schröck E, du Manoir S, Veldman T, Schoell B, Wienberg J, Ferguson-Smith M, Ning Y, Ledbetter D, et al: Multicolor spectral karyotyping of human chromosomes. Science 273:494–497 (1996).
41.
Shizuya H, Birren B, Kim UJ, Mancino V, Slepak T, Tachiiri Y, Simon M: Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector. Proc Natl Acad Sci USA 89:8794–8797 (1992).
42.
Sobolev B, Heidenreich WF, Kairo I, Jacob P, Goulko G, Likhtarev I: Thyroid cancer incidence in the Ukraine after the Chernobyl accident: comparison with spontaneous incidences. Radiat Environ Biophys 36:195–199 (1997).
43.
Veldman T, Vignon C, Schröck E, Rowley JD, Ried T: Hidden chromosome abnormalities in haematological malignancies detected by multicolour spectral karyotyping. Nat Genet 15:406–410 (1997).
44.
Ward LS, Brenta G, Medvedovic M, Fagin JA: Studies of allelic loss in thyroid tumors reveal major differences in chromosomal instability between papillary and follicular carcinomas. J Clin Endocrin Metabol 83:525–530 (1998).
45.
Weier HUG, Chu LW: Quantitative DNA fiber mapping in genome research and construction of physical maps, in Bina M (ed): Methods in Molecular Biology, vol 338 pp 31–58 Gene Mapping, Discovery, and Expression: Methods and Protocols. (Humana Press, Totowa 2005).
46.
Weier HUG, Rhein AP, Shadravan F, Collins C, Polikoff D: Rapid physical mapping of the human <X_Underline>trk</X_Underline> proto-oncogene (NTRK1) gene to human chromosome 1q21–q22 by P1 clone selection, fluorescence in situ hybridization (FISH) and computer-assisted microscopy. Genomics 26:390–393 (1995).
47.
Willadsen S, Levron J, Munné S, Schimmel T, Márquez C, Scott R, Cohen J: Rapid visualization of metaphase chromosomes in single human blastomeres after fusion with in vitro matured bovine eggs. Hum Reprod 14:470–475 (1999).
48.
Williams D, Pinchera A, Karaoglou A, Chadwick KH: Thyroid cancer in children living near Chernobyl. Expert panel report on the consequences of the Chernobyl accident. Directorate General EUR15248EN: Commission of the European Communities, Luxemburg (1993).
49.
Zitzelsberger H, Lehmann L, Hieber L, Weier HUG, Janish C, Fung J, Negele T, Spelsberg F, et al: Cytogenetic changes in radiation-induced tumors of the thyroid. Cancer Res 59:135–140 (1999).
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.